Rhumbline Advisers Sells 7,910 Shares of Globe Life Inc. $GL

Rhumbline Advisers lessened its stake in Globe Life Inc. (NYSE:GL) by 3.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 204,400 shares of the company’s stock after selling 7,910 shares during the period. Rhumbline Advisers’ holdings in Globe Life were worth $29,223,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. Mather Group LLC. bought a new stake in Globe Life in the third quarter valued at approximately $28,000. CYBER HORNET ETFs LLC acquired a new position in shares of Globe Life in the 2nd quarter worth approximately $28,000. Assetmark Inc. boosted its stake in shares of Globe Life by 777.8% in the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after purchasing an additional 210 shares during the last quarter. MUFG Securities EMEA plc acquired a new stake in shares of Globe Life during the second quarter worth $31,000. Finally, Quent Capital LLC bought a new position in Globe Life during the third quarter worth $36,000. 81.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on GL. Morgan Stanley reaffirmed an “overweight” rating and set a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Piper Sandler reiterated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a report on Friday, November 21st. JPMorgan Chase & Co. boosted their price target on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday. Finally, TD Cowen reiterated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $171.00.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,036,943.24. The trade was a 20.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Clay Majors sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $146.89, for a total value of $4,406,700.00. Following the sale, the executive vice president directly owned 47,066 shares of the company’s stock, valued at $6,913,524.74. This represents a 38.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 51,129 shares of company stock valued at $7,414,035 over the last ninety days. 1.97% of the stock is currently owned by corporate insiders.

Globe Life Stock Up 0.2%

Shares of NYSE:GL opened at $144.46 on Monday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 52-week low of $109.38 and a 52-week high of $152.71. The business’s 50 day simple moving average is $140.57 and its two-hundred day simple moving average is $138.39. The firm has a market cap of $11.50 billion, a P/E ratio of 10.26 and a beta of 0.47.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the company earned $3.14 earnings per share. Globe Life’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, research analysts forecast that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.